Brief: MaxCyte Q3 Revenue USD 8.2 Million Vs. IBES Estimate USD 7.37 Million
06/11/2024 21:05
Nov 06 (Reuters) - MaxCyte Q3 cash & investments USD 196.6 million. * Q3 gross profit USD 6.2 million * Q3 operating expenses USD 20.3 million * Q3 adjusted EBITDA USD -13 million * Q3 net income USD -11.6 million
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview